The Timing and Covid antibodies key for plasma treatment effectiveness, a new study finds


A new study in the New England Journal of Medicine reports a lower risk of death for patients with Covid-19 who receive high-level antibody plasma treatment within days of hospitalization.

0 comments

© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.